{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:16:08Z","timestamp":1789665368439,"version":"4.0.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Psoriasis is characterized by keratinocyte proliferation and immune cell infiltration. M2 isoform of pyruvate kinase (PKM2) was reported to have an important role in cell proliferation, which is a rate-limiting enzyme that regulates the final step of glycolysis. However, how PKM2 regulates cell metabolism and proliferation in psoriatic keratinocytes is still poorly understood. Interestingly, we found that PKM2 was highly expressed in psoriatic epidermis from patients and mouse models. PKM2 overexpression promoted keratinocyte glycolytic metabolism while knockdown inhibited keratinocyte proliferation and glycolysis. Mice lacking PKM2 specifically in keratinocytes, pharmacological inhibition of PKM2 or glycolysis inhibited keratinocyte proliferation and showed obvious remission in an imiquimod-induced psoriatic mouse model. Moreover, the inhibitor of the EGF-receptor blocked EGF-stimulated PKM2 expression and glycolysis in keratinocytes. We identify PKM2 as an upregulated gene in psoriasis. PKM2 is essential in keratinocyte over-proliferation and may represent a therapeutic target for psoriasis.<\/jats:p>","DOI":"10.3389\/fphar.2021.765790","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T15:39:18Z","timestamp":1634657958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation"],"prefix":"10.3389","volume":"12","author":[{"given":"Yun-zi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-zhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-qian-zhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-kuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"173088","DOI":"10.1016\/j.ejphar.2020.173088","article-title":"Therapeutic Treatment with Ibrutinib Attenuates Imiquimod-Induced Psoriasis-like Inflammation in Mice through Downregulation of Oxidative and Inflammatory Mediators in Neutrophils and Dendritic Cells","volume":"877","author":"Al-Harbi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The Interplay between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate Kinase M2 Activators Promote Tetramer Formation and Suppress Tumorigenesis","volume":"8","author":"Anastasiou","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1055\/s-0033-1350934","article-title":"Pharmacological Properties of Shikonin - a Review of Literature since 2002","volume":"79","author":"And\u00fajar","year":"2013","journal-title":"Planta Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/RLU.0b013e3181feedff","article-title":"Incidental Finding of F-18 FDG Skin Uptake in a Patient with Psoriasis during the Evaluation of a Recurrent Papillary Thyroid Carcinoma","volume":"36","author":"Bruna-Muraille","year":"2011","journal-title":"Clin. Nucl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its Analogs Inhibit Cancer Cell Glycolysis by Targeting Tumor Pyruvate Kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"B7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 Splice Isoform of Pyruvate Kinase Is Important for Cancer Metabolism and Tumour Growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/bj0620057","article-title":"The Oxygen Uptake, Glucose Utilization and Lactic Acid Production of guinea-pig Skin in Relation to Oxygen Tension","volume":"62","author":"Cruickshank","year":"1956","journal-title":"Biochem. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental Design and Analysis and Their Reporting II: Updated and Simplified Guidance for Authors and Peer Reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/ced.12356","article-title":"Effect of Psoriasis Activity on Epidermal Growth Factor (EGF) and the Concentration of Soluble EGF Receptor in Serum and Plaque Scales","volume":"39","author":"Flisiak","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to Cytokines: Mechanistic Insights from the Imiquimod Mouse Model of Psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","article-title":"Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase","volume":"45","author":"Gao","year":"2012","journal-title":"Mol. Cel."},{"key":"B13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy--analysis of Affymetrix GeneChip Data at the Probe Level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s12276-021-00620-z","article-title":"2'-Hydroxycinnamaldehyde Ameliorates Imiquimod-Induced Psoriasiform Inflammation by Targeting PKM2-STAT3 Signaling in Mice","volume":"53","author":"Hao","year":"","journal-title":"Exp. Mol. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2020.06.024","article-title":"Inhibiting Protein Kinase Activity of Pyruvate Kinase M2 by SIRT2 Deacetylase Attenuates Psoriasis","volume":"141","author":"Hao","year":"","journal-title":"J. Invest. Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jid.2017.10.013","article-title":"Research Techniques Made Simple: Murine Models of Human Psoriasis","volume":"138","author":"Hawkes","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"110656","DOI":"10.18632\/oncotarget.22529","article-title":"PKM2 in Carcinogenesis and Oncotherapy","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"B18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12943-018-0791-3","article-title":"Pyruvate Kinase M2 Fuels Multiple Aspects of Cancer Cells: from Cellular Metabolism, Transcriptional Regulation to Extracellular Signaling","volume":"17","author":"Hsu","year":"2018","journal-title":"Mol. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jid.2016.11.007","article-title":"Recent Highlights in Psoriasis Research","volume":"137","author":"Hwang","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","article-title":"The Mitogen-Activated Protein Kinases P38 and ERK1\/2 Are Increased in Lesional Psoriatic Skin","volume":"152","author":"Johansen","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/bjd.15008","article-title":"Exploration of Candidate Biomarkers for Human Psoriasis Based on Gas Chromatography-Mass Spectrometry Serum Metabolomics","volume":"176","author":"Kang","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1126\/science.1224409","article-title":"SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions","volume":"338","author":"Keller","year":"2012","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"135S","DOI":"10.1111\/1523-1747.ep12876121","article-title":"Role of Growth Factors, Cytokines, and Their Receptors in the Pathogenesis of Psoriasis","volume":"94","author":"Krueger","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2579","DOI":"10.1038\/cddis.2016.460","article-title":"NLRP3 Inflammasome Activation Mediates Radiation-Induced Pyroptosis in Bone Marrow-Derived Macrophages","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings","volume":"133","author":"Martin","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0360-3016(96)85017-6","article-title":"Improving Cancer Radiotherapy with 2-Deoxy-D-Glucose: Phase I\/II Clinical Trials on Human Cerebral Gliomas","volume":"35","author":"Mohanti","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B30","doi-asserted-by":"publisher","first-page":"106215","DOI":"10.1016\/j.intimp.2020.106215","article-title":"Bruton's Tyrosine Kinase Inhibitor Suppresses Imiquimod-Induced Psoriasis-like Inflammation in Mice through Regulation of IL-23\/IL-17A in Innate Immune Cells","volume":"80","author":"Nadeem","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biochi.2020.09.023","article-title":"Inhibition of Interleukin-2-Inducible T-Cell Kinase Causes Reduction in Imiquimod-Induced Psoriasiform Inflammation through Reduction of Th17 Cells and Enhancement of Treg Cells in Mice","volume":"179","author":"Nadeem","year":"","journal-title":"Biochimie"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pnpbp.2017.12.015","article-title":"Systemic Inflammation in Asocial BTBR T+ Tf\/J Mice Predisposes Them to Increased Psoriatic Inflammation","volume":"83","author":"Nadeem","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/1523-1747.ep12285389","article-title":"Altered [125I]epidermal Growth Factor Binding and Receptor Distribution in Psoriasis","volume":"86","author":"Nanney","year":"1986","journal-title":"J. Invest. Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/s0959-8049(01)00231-3","article-title":"EGFR and Cancer Prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.1016\/s0021-9258(18)67091-7","article-title":"The M1- and M2-type Isozymes of Rat Pyruvate Kinase Are Produced from the Same Gene by Alternative RNA Splicing","volume":"261","author":"Noguchi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of Psoriasis and Development of Treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J. Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jdermsci.2011.04.011","article-title":"Differential Modulation of Stress-Inflammation Responses by Plant Polyphenols in Cultured normal Human Keratinocytes and Immortalized HaCaT Cells","volume":"63","author":"Pastore","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1046\/j.1365-2133.1999.03152.x","article-title":"Growth Inhibition of Psoriatic Keratinocytes by Quinazoline Tyrosine Kinase Inhibitors","volume":"141","author":"Powell","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","article-title":"Guselkumab (An IL-23-specific mAb) Demonstrates Clinical and Molecular Response in Patients with Moderate-To-Severe Psoriasis","volume":"133","author":"Sofen","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod Has Strain-dependent Effects in Mice and Does Not Uniquely Model Human Psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced Psoriasis-like Skin Inflammation in Mice Is Mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg Effect: the Metabolic Requirements of Cell Proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B43","first-page":"6665","article-title":"Suppressive Effect of \u03b2, \u03b2-dimethylacryloyl Alkannin on Activated Dendritic Cells in an Imiquimod-Induced Psoriasis Mouse Model","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 Regulates \u03b2-catenin Transactivation upon EGFR Activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent Phosphorylation and Nuclear Translocation of PKM2 Promotes the Warburg Effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1475-2840-12-75","article-title":"Role of Kir6.2 Subunits of ATP-Sensitive Potassium Channels in Endotoxemia-Induced Cardiac Dysfunction","volume":"12","author":"Yang","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jid.2016.03.035","article-title":"Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis","volume":"136","author":"Yiu","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41419-020-03028-1","article-title":"EZH2-dependent Epigenetic Modulation of Histone H3 Lysine-27 Contributes to Psoriasis by Promoting Keratinocyte Proliferation","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.765790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T15:40:04Z","timestamp":1634658004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.765790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":48,"alternative-id":["10.3389\/fphar.2021.765790"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.765790","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"article-number":"765790"}}